Abstract
Lithium is the primary choice for preventing bipolar disorder relapses, endorsed by guidelines. A recent systematic review by Ulrichsen et al. showed limitations in assessing its specific impact, but data supports lithium's effectiveness in managing symptoms and preventing relapse. Comprehensive guidelines and research are crucial for its continued use.
Originalsprog | Engelsk |
---|---|
Artikelnummer | e187 |
Tidsskrift | BJPsych open |
Vol/bind | 9 |
Udgave nummer | 6 |
Antal sider | 2 |
ISSN | 2056-4724 |
DOI | |
Status | Udgivet - nov. 2023 |